HR 124In Committee
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Introduced January 3, 2025
Summary
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic]This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Timeline
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
See how this bill affects you
Enter your details to get a personalized impact estimate.
Check your impact